Mesoblast Limited (ASX:MSB)
2.400
-0.090 (-3.61%)
Sep 26, 2025, 4:10 PM AEST
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
323.85K AUD
Profits / Employee
-1.92M AUD
Market Cap
3.07B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 29,904 |
Pro Medicus | 132 |
Cochlear | 5,500 |
Sonic Healthcare | 45,000 |
Ramsay Health Care | 90,000 |
Telix Pharmaceuticals | 234 |
Ansell | 15,000 |
Neuren Pharmaceuticals | 8 |
Mesoblast News
- 2 days ago - Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs - GlobeNewsWire
- 13 days ago - Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences - GlobeNewsWire
- 24 days ago - Mesoblast enters option to issue $50M convertible notes - Seeking Alpha
- 24 days ago - Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes - GlobeNewsWire
- 4 weeks ago - Mesoblast Limited (MESO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Mesoblast Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Full Year 2025 Mesoblast Ltd Earnings Presentation Transcript - GuruFocus
- 4 weeks ago - Mesoblast (MESO) Sees Revenue Surge in FY25 with Ryoncil's FDA Approval - GuruFocus